Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
- Z. Nasreddine, N. Phillips, +5 authors H. Chertkow
- MedicineJournal of the American Geriatrics Society
- 1 April 2005
A 10‐minute cognitive screening tool (Montreal Cognitive Assessment, MoCA) to assist first‐line physicians in detection of mild cognitive impairment (MCI), a clinical state that often progresses to dementia.
The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
The workgroup sought to ensure that the revised criteria would be flexible enough to be used by both general healthcare providers without access to neuropsychological testing, advanced imaging, and cerebrospinal fluid measures, and specialized investigators involved in research or in clinical trial studies who would have these tools available.
Our concepts about objects, states, and events are stored in a cognitive structure termed semantic memory. There are several types of neurologic disorders that may cause impairments of semantic…
Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample
A population-based study of scores on the Montreal Cognitive Assessment (MoCA) in Texas found substantial effects of age and education on their MoCA scores.
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup
The workgroup sought to ensure that the revised criteria for Alzheimer’s disease (AD) dementia would be flexible enough to be used by both general healthcare providers without access to neuropsychological testing, advanced imaging, and cerebrospinal fluid measures, and specialized investigators involved in research or in clinical trial studies who would have these tools available.
Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease.
- V. Singh, H. Chertkow, J. Lerch, Alan C. Evans, A. Dorr, N. Kabani
- Psychology, MedicineBrain : a journal of neurology
- 1 November 2006
These novel findings support the notion of increased isocortical involvement with the progression of disease, as a specific pattern in the thinning of the cortical ribbon is shown which is in agreement with the previous histological reports.
Multilingualism (But Not Always Bilingualism) Delays the Onset of Alzheimer Disease: Evidence From a Bilingual Community
- H. Chertkow, V. Whitehead, N. Phillips, C. Wolfson, Julie Atherton, H. Bergman
- Psychology, MedicineAlzheimer disease and associated disorders
- 1 April 2010
A small but significant protective effect of more than 2 languages spoken is found in bilinguals overall in relation to age at diagnosis or age at symptom onset, but the results mirrored those of Bialystok et al with 2 or more languages delaying the diagnosis of Alzheimer disease by almost 5 years.
Semantic memory loss in dementia of Alzheimer's type. What do various measures measure?
It was shown that semantic cueing and semantic priming, using the same words whose concepts were degraded in semantic memory, yielded an entirely different pattern of results, and Cueing and priming therefore may not be used interchangeably in the study of semantic loss after brain damage.
Olfaction in patients with mild cognitive impairment and Alzheimer's disease
- J. Djordjevic, M. Jones-Gotman, Kathy De Sousa, H. Chertkow
- Medicine, PsychologyNeurobiology of Aging
- 1 May 2008
It is concluded that deficits in olfactory detection thresholds and identification occur early in AD, before clinical symptoms are fully developed, and decline further over the course of the disease.
Validity of a novel computerized cognitive battery for mild cognitive impairment
Mindstreams tests are effective in detecting MCI, providing a comprehensive profile of cognitive function, and the enhanced precision and ease of use of these computerized tests make the NeuroTrax system a valuable clinical tool in the identification of elderly at high risk for dementia.